Edward Wirth is Chief Medical Officer at Asterias Biotherapeutics, Inc. (AST). They have made 1 open-market trade across 1 company since 2015, most recently 2019-03-01.
CIK 0001572552
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AST | 316,020 | $299K |
Shares reported on the most recent Form 4, priced at the 2019-03-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AST | SELL · 10b5-1 | 2017-01-09 | 2017-01-11 | $4.60 | $16K | +5.4% | -19.4% | -34.4% |
| AST | SELL · 10b5-1 | 2016-12-27 | 2017-01-06 | $5.00 | $13K | -3.2% | -20.2% | -37.2% |
| AST | SELL · 10b5-1 | 2016-11-17 | 2016-11-21 | $5.00 | $13K | -22.4% | -16.8% | -31.8% |
| AST | SELL | 2016-10-06 | 2016-10-11 | $4.12 | $28K | -10.8% | -9.5% | +16.8% |
| AST | SELL · 10b5-1 | 2016-09-08 | 2016-09-12 | $3.52 | $52K | +21.8% | -6.4% | +6.4% |
| AST | SELL · 10b5-1 | 2015-09-15 | 2015-09-16 | $6.00 | $17K | -32.5% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.